Open Government Canada
Canada’s regulatory approach to drugs for rare diseases: orphan drugs
Published by Health Canada | Santé Canada
About this dataset
Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.